Virtual Clinical Trials: Testing new drugs from afar

by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and they can take up to a decade to fully complete. Not only can this represent a substantial strain on a pharmaceutical company, it also … Continue reading Virtual Clinical Trials: Testing new drugs from afar

Slow and Steady Drug Delivery Keeps Biomedical Devices Kicking

Researchers from MIT have developed a novel method to locally deliver drugs and prevent immune activity around implanted biomedical devices over several months. The method is based on the formation of crystals of immunosuppressive drugs, which can be included in devices and slowly dissolve over the course of months. While this method substantially increases the length of time tested devices can function, difficulty of crystallizing certain drugs or introducing them into specific devices may prove to be a challenge in adapting this method to other systems. Even so, for many cases, this method will likely substantially reduce the difficulty of maintaining device stability for extended periods of time. Continue reading Slow and Steady Drug Delivery Keeps Biomedical Devices Kicking

Artificial Intelligence in Medicine: Applications, implications, and limitations

by Daniel Greenfield figures by Sean Wilson The future of ‘standard’ medical practice might be here sooner than anticipated, where a patient could see a computer before seeing a doctor. Through advances in artificial intelligence (AI), it appears possible for the days of misdiagnosis and treating disease symptoms rather than their root cause to move behind us. Think about how many years of blood pressure measurements … Continue reading Artificial Intelligence in Medicine: Applications, implications, and limitations